Soft tissue regeneration company Aroa Biosurgery is aiming to list on the ASX by the end of July - that "would be the goal" says chief executive Brian Ward.
Despite remaining New Zealand-based, Ward said a New Zealand listing was not the best option for Aroa.
Ward said, “For us, there’s a
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
